Trial Profile
A prospective phase II study of preoperative, controlled exisulind therapy initiated prior to radical prostatectomy: effect on apoptosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Exisulind (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 04 Oct 2005 New trial record.